The Cell Factory Overview

  • Founded
  • 2007
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series A
  • (Cancelled)
  • Investors
  • 1

The Cell Factory General Information

Description

Developer of immunotherapeutic drug candidates designed to make affordable regenerative medicine. The company's drug candidates are focused on development, clinical translation and commercialization of extracellular vesicles biologic drugs and autologous stem cell therapies, enabling doctors to meet the needs of their patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • Galileilaan 19
  • 2845 Niel
  • Belgium
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

The Cell Factory Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series A) 29-Nov-2018 Cancelled Generating Revenue
2. Grant 05-Mar-2018 00.000 Completed Generating Revenue
1. Later Stage VC 24-Jan-2014 $2.05M $2.05M 00.000 Completed Generating Revenue
To view The Cell Factory’s complete valuation and funding history, request access »

The Cell Factory Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 0,000 00000.00 00000.00 00 00000.00 00.000
To view The Cell Factory’s complete cap table history, request access »

The Cell Factory Executive Team (1)

Name Title Board Seat Contact Info
Frederic Amar Chief Executive Officer
To view The Cell Factory’s complete executive team members history, request access »

The Cell Factory Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Horizon 2020 Government 000 0000 000000 0
To view The Cell Factory’s complete investors history, request access »